GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline
About GALVmed
Neurocysticercosis, a human disease transmitted from pigs with porcine cysticercosis (PC), causes 30% of human epilepsy cases in the developing world.
The disease is estimated to cause around 5 million human cases and 50,000 human deaths each year.
This is a disease that affects the poor and those who have neurocysticercosis are often stigmatised in their communities.
The first-ever licensed PC vaccine became available in India at the end of 2016 at US $1 for 2 doses to vaccinate a pig.
Product development
GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.
Policy and advocacy
The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.
A simple diagnostic device is enabling farmers in Cameroon to test for the deadly livestock disease Animal African Trypanosomiasis (AAT or Tryps).
AAT is caused mainly by two parasite species, Trypanosoma vivax and Trypanosoma congolense, which …
In the rural villages of central Uganda’s Mukono and Mityana districts and eastern Uganda’s Iganga district, thanks to the introduction of the Newcastle Disease vaccine (I-2 ND) which protects poultry against this deadly disease, women …
Access to a vaccine for Newcastle Disease (ND) has transformed the lives of communities in the Mayurbhanj district of Odisha state.
Local inhabitants, who have traditionally bred poultry, would often experience the death of their flock …
